Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco Global Buyback Achievers UCITS ETF Dist

BUYB · IE00BLSNMW37 · class Dist · USD · domicile Ireland
Equity · North AmericaSFDR art. 6
Index tracked: NASDAQ Global Buyback Achievers NTR Index
TER
0.39%+ trans. 0.18%
Fund size
173 m EUR
Tracking difference
−0.29%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingquarterly
Launch 24 Oct 2014 · costs from the KID as of 14 Aug 2026 · 430 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
- The objective of the Fund is to provide investors with investment results which, before expenses, correspond to the price and yield performance of the NASDAQ Global Buyback Achievers Index (Net Total Return) in USD (the "Index"). - The Fund’s base currency is USD. - The Index is comprised of securities from the NASDAQ US Buyback Achievers Index (comprised of corporations listed on The NASDAQ Stock Market, the New York Stock Exchange or NYSE MKT that have effected a net reduction in shares outstanding of 5% or more in the trailing twelve months) and…

Performance since series start (in euro) — base 100

24 Oct 20141 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201520172019202120232025413100413
High 413 (1 Sept 2026) · low 100 (24 Oct 2014) · last 413. Past performance is not indicative of future results.

Returns in euro

1 year+23.1%
3 years+66.8%
5 years+71.5%
10 years+220.6%
Since series start+312.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)10.10%12.01%13.95%
Max drawdown−6.81%−15.52%−28.09%
Sharpe1.881.270.51
Sortino2.871.770.71
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · BUYB · IE00BLSNMW371
RebalixBUYB · IE00BLSNMW37 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+30.04%+30.45%−0.41%
2024+12.83%+13.12%−0.29%
2023+15.18%+15.35%−0.17%
2022−11.23%−10.83%−0.40%
2021+19.48%+19.71%−0.23%

Distributions · per share, in USD

Frequency: quarterly · last 12 months: 1.2493 USD (1.58% of NAV) · last ex-date 10 Sept 2026
YearPaymentsTotal (USD)Dividend yield
202630.8323
202541.2774+2.38%
202440.9876+2.04%
202340.8301+1.94%
202240.8198+1.66%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 430 securities · top-10 weight = 37.0%
Top holdingsWeight
SHELL PLC GBP 0.07005.5%
BANK OF AMERICA CORP USD0.015.0%
NOVARTIS AG-REG CHF0.54.7%
WELLS FARGO & CO USD1.6664.6%
CITIGROUP INC USD0.013.9%
SALESFORCE INC USD 0.0013.6%
SCHWAB (CHARLES) CORP USD0.013.2%
MITSUBISHI CORP NPV2.4%
ING GROEP NV EUR0.012.3%
ADOBE INC USD0.00011.9%
Countries (% of fund)
United States69.2%Japan13.0%United Kingdom4.5%Other3.9%China2.4%
Sectors (% of fund)
Financials36.7%Energy11.8%Industrials11.0%Information Technology10.8%Consumer Discretionary10.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
BUYB · Borsa Italiana (ETFplus)
BBCK · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BLSNMW37
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · BUYB · IE00BLSNMW372